Alessandra Corte Real Salgues

Alessandra Corte Real Salgues

Auto-generated profile, based on publicly available information

Alessandra Corte Real Salgues

Oncology Center, Hospital Sírio-Libanês (HSL), São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2020 in Immunotherapy
Verified
Journal Article
Open access
CCCesar Martins da Costa
Cesar Martins da Costa
ZSZenaide Silva Souza
Zenaide Silva Souza
ASAlessandra Corte Real Salgues
Alessandra Corte Real Salgues
GHGuilherme Harada
Guilherme Harada
PAPedro Paulo Marino Rodrigues Ayres
Pedro Paulo Marino Rodrigues Ayres
RMRodrigo Ramella Munhoz
Rodrigo Ramella Munhoz
Background: Little is known about the 2019 novel coronavirus disease (COVID-19) course and outcomes in patients receiving immunotherapy. Here we describe a metastatic Merkel cell carcinoma patient ...

10 May 2021 in European Journal of Hybrid Imaging
Verified
Journal Article
Open access
PDF file
MQMarcello Moro Queiroz
Marcello Moro Queiroz
CLCarlos Diego H Lopes
Carlos Diego H Lopes
ASAlessandra Corte Real Salgues
Alessandra Corte Real Salgues
FBFelipe de Galiza Barbosa
Felipe de Galiza Barbosa
EAEmerson Shigueaki Abe
Emerson Shigueaki Abe
FCFernanda Cunha Capareli
Fernanda Cunha Capareli
Background: Pancreatic neuroendocrine tumor (PNET) is a subgroup of neuroendocrine tumor (NET) that has unique biology and natural history. The histological classification has a major role in the management of this pathology, but in recent years Gallium 68 dotatate (68Ga-DOTA) scanning is at the center of a discussion about how these imaging technologies can modify clinical management of neuroendocrine tumors and how their results are correlated to Ki67 index. Method: We hereby describe a case of a patient that investigated an unspecific stable pancreatic nodule suspected of high-grade NET after evaluation with 68Ga-DOTATOC positron emission tomography—computed tomography (PETCT) and 18F-Fluorodeoxyglucose (18F-FDG) PETCT. Results: The images corroborate the hypothesis of high-grade NET based on the standard uptake value (SUV) described in both image exams (16.4 in 18FDG PETCT and 9.2 in 68Ga-DOTATOC PETCT). After surgery, the histopathological analyses revealed a localized grade 2 well-differentiated NET, Ki-67 of 4.7, glucose transport proteins 1 (GLUT1) negative by immunohistochemistry, evidencing a rare case of mismatch between the functional image and the in vivo characterization of the neoplasm. Conclusion: Functional imaging of neuroendocrine tumors with different modalities of PETCT is a well-described strategy for evaluating PNET and can dictate conducts in some cases. However, histopathological analysis is crucial to confirm the grade and prognosis related to this disease.

4 March 2022 in Case Reports in Oncology
Verified
Journal Article
Open access
PDF file
BCBeatriz Mendes Awni Cidale
Beatriz Mendes Awni Cidale
CLCarlos Diego H Lopes
Carlos Diego H Lopes
GHGuilherme Harada
Guilherme Harada
ASAlessandra Corte Real Salgues
Alessandra Corte Real Salgues
GFGilmar de Andrade França
Gilmar de Andrade França
RMRodrigo Ramella Munhoz
Rodrigo Ramella Munhoz
Werner’s syndrome is caused by the inactivation of both WRN alleles and is characterized by premature aging and increased risk of neoplasms, especially those of mesenchymal origins, such as sarcomas. Given the characteristic genomic instability, patients with this syndrome are more susceptible to develop toxicities when exposed to cytotoxic agents, such as alkylators and anthracyclines. The impact of the monoallelic WRN mutation on treatment-associated toxicities is poorly understood. Here, we report a patient with locally advanced dedifferentiated liposarcoma of the retroperitoneum harboring a heterozygous germline inactivation mutation in the WRN gene, who was treated with a classic regimen of ifosfamide and doxorubicin and developed exacerbated and prolonged hematological and renal toxicities.